Metabolic and therapeutic effects of allopurinol in patients with leukemia and gout
Data up to Jan 2025
Total Citations Per Year
Abstract
References (17)
Enzymatic Determination of Uric Acid with Detailed Directions
1953 • 307 citations
Potentiation by inhibition of drug degradation : 6-substituted purines and xanthine oxidase
1963 • 305 citations
Allopurinol in the Treatment of Gout
1966 • 240 citations
Effect of allopurinol (4-Hydroxypyrazolo-(3,4-d)pyrimidine) on serum and urinary uric acid in primary and secondary gout
1964 • 228 citations
The Effectiveness of the Xanthine Oxidase Inhibitor Allopurinol in the Treatment of Gout
1965 • 211 citations
Pseudofeedback Inhibition of Purine Synthesis by 6-Mercaptopurine Ribonucleotide and Other Purine Analogues
1964 • 168 citations
Effects of a xanthine oxidase inhibitor on thiopurine metabolism, hyperuricemia and gout
2001 • 158 citations
THE FATE OF 6‐MERCAPTOPURINE IN MICE
1954 • 153 citations
Prevention of Hyperuricemia in Leukemia and Lymphoma
1965 • 134 citations
Uric acid excretion and renal function in the acute hyperuricemia of leukemia
1964 • 133 citations
RELATIONSHIP BETWEEN METABOLIC FATES AND ANTITUMOR ACTIVITIES OF THIOPURINES.
1963 • 113 citations
THE FATE OF 6‐MERCAPTOPURINE IN MAN
1954 • 85 citations
Augmentation of the incorporation of hypoxanthine into nucleic acids by the administration of an inhibitor of xanthine oxidase
1963 • 79 citations
Xanthinuria and Hemochromatosis
1964 • 61 citations
Acute Uric Acid Nephropathy
1963 • 44 citations
Allopurinol in the Treatment of Gout
1965 • 41 citations
Effects of Xanthine Oxidase Inhibitor on Clinical Manifestations and Purine Metabolism in Gout.
1964 • 31 citations
Cited By (0)
No citing papers found in database